Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T63505 | Target Info | |||
Target Name | Tyrosine-protein kinase ABL1 (ABL) | ||||
Synonyms | p150; Proto-oncogene tyrosine-protein kinase ABL1; Proto-oncogene c-Abl; JTK7; C-ABL; Abl; Abelson tyrosine-protein kinase 1; Abelson murine leukemia viral oncogene homolog 1 | ||||
Target Type | Successful Target | ||||
Gene Name | ABL1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 3 Acyltransferases | + | |||
Interacting Target Name | Signal transduction protein CBL (CBL) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF55; RING-type E3 ubiquitin transferase CBL; RING finger protein 55; Proto-oncogene c-CBL; E3 ubiquitin-protein ligase CBL; C-Cbl; CBL2; Casitas B-lineage lymphoma proto-oncogene | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Biochemical Activity | [3] | |||
4 | Far Western | [3] | |||
5 | Reconstituted Complex | [4] | |||
Interacting Protein Name | Breast cancer type 1 susceptibility protein (BRCA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BRCAI; BRCC1; BROVCA1; FANCS; IRIS; PNCA4; PPP1R53; PSCP; RNF53 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Biochemical Activity | [5] | |||
3 | Fluorescence Resonance Energy Transfer | [6] | |||
4 | Reconstituted Complex | [5] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase parkin (PRKN) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AR.JP; LPRS2; PDJ; PRKN | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Biochemical Activity | [7] | |||
3 | Reconstituted Complex | [8] | |||
Adapter proteins | [+] 2 Adapter proteins | + | |||
Interacting Protein Name | Growth factor receptor-bound protein 2 (GRB2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SH2/SH3 adapter GRB2; Protein Ash; Growth factor receptor-bound protein 2; ASH; Adapter protein GRB2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [9] | |||
3 | Reconstituted Complex | [10] | |||
4 | Yeast two hybrid | [10] | |||
Interacting Target Name | NCK adaptor protein 1 (NCK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SH2/SH3 adaptor protein NCK-alpha; SH2/SH3 adaptor protein NCKalpha; Nck-1; Nck1; NCK; Cytoplasmic protein NCK1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Reconstituted Complex | [10] | |||
3 | Yeast two hybrid | [10] | |||
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Protein Name | 14-3-3 protein zeta/delta (YWHAZ) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3.zeta; HEL.S.3; HEL4; KCIP.1; YWHAD | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [12] | |||
2 | Affinity Capture-Western | [12] | |||
3 | Co-localization | [12] | |||
Cell division cycle proteins | [+] 1 Cell division cycle proteins | + | |||
Interacting Protein Name | Retinoblastoma-associated protein (RB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | OSRC; PPP1R130; RB; p105.Rb; pRb; pp110 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Reconstituted Complex | [14] | |||
Ester hydrolases | [+] 2 Ester hydrolases | + | |||
Interacting Protein Name | MutS protein homolog 5 (MSH5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G7; MUTSH5; NG23 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Biochemical Activity | [15] | |||
3 | Yeast two hybrid | [16] | |||
Interacting Protein Name | Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (INPPL1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | OPSMD; SHIP2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [17] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [18] | |||
2 | Affinity Capture-Western | [19] | |||
Kinases | [+] 8 Kinases | + | |||
Interacting Target Name | ATM serine/threonine kinase (ATM) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine-protein kinase ATM; Ataxia telangiectasia mutated; A-T mutated | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [20] | |||
2 | Biochemical Activity | [21] | |||
3 | Reconstituted Complex | [22] | |||
4 | Yeast two hybrid | [22] | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Protein-Fragment Complementation Assay | [23] | |||
2 | Yeast two hybrid | [24] | |||
Interacting Target Name | Erbb2 tyrosine kinase receptor (HER2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase-type cell surface receptor HER2; Tyrosine kinase receptor ErbB2; Receptor tyrosine-protein kinase erbB-2; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; P185erbB2; NGL; NEU proto-oncogene; NEU; MLN19; MLN 19; Metastatic lymph node gene 19 protein; HER2/neu; HER2 (erbB2/neu); HER-2; Erb2; Epidermal growth factor receptor 2; C-erbB-2 oncoprotein; C-erbB-2; CD340 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Protein-peptide | [25] | |||
2 | Reconstituted Complex | [26] | |||
Interacting Target Name | Tropomyosin-related kinase A (TrkA) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase receptor A; Tyrosine kinase receptor; Trk-A; TRKA; TRK1-transforming tyrosine kinase protein; TRK1 transforming tyrosinekinase protein; TRK; P140-TrkA; NGF-trk receptor type A; Neurotrophic tyrosine kinase receptor type 1; MTC; High affinity nerve growth factor receptor; gp140trk | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [27] | |||
2 | Yeast two hybrid | [28] | |||
Interacting Target Name | Serine/threonine-protein kinase ATR (FRP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FRAP-related protein 1; Ataxia telangiectasia and Rad3-related protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [29] | |||
2 | Protein-peptide | [30] | |||
Interacting Target Name | Tyrosine-protein kinase ABL2 (ABL2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase ARG; ARG; ABLL; Abelson-related gene protein; Abelson tyrosine-protein kinase 2; Abelson murine leukemia viral oncogene homolog 2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Reconstituted Complex | [31] | |||
Interacting Protein Name | Breakpoint cluster region protein (BCR) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ALL; BCR1; CML; D22S11; D22S662; PHL | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [32] | |||
2 | Reconstituted Complex | [33] | |||
Interacting Protein Name | Phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AGM7; GRB1; IMD36; p85; p85.ALPHA | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Reconstituted Complex | [34] | |||
Proteins 14-3-3 | [+] 5 Proteins 14-3-3 | + | |||
Interacting Target Name | AS1 14-3-3 protein eta (YWHAH) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | YWHA1; Protein AS1; 14-3-3 protein eta | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [12] | |||
2 | Affinity Capture-Western | [12] | |||
Interacting Protein Name | 14-3-3 protein beta/alpha (YWHAB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GW128; HEL.S.1; HS1; KCIP.1; YWHAA | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [12] | |||
2 | Affinity Capture-Western | [12] | |||
Interacting Protein Name | 14-3-3 protein epsilon (YWHAE) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3E; HEL2; KCIP.1; MDCR; MDS | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [12] | |||
2 | Affinity Capture-Western | [12] | |||
Interacting Protein Name | 14-3-3 protein gamma (YWHAG) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3GAMMA; PPP1R170 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [12] | |||
2 | Affinity Capture-Western | [12] | |||
Interacting Protein Name | 14-3-3 protein theta (YWHAQ) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 14.3.3; 1C5; HS1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [12] | |||
2 | Affinity Capture-Western | [12] | |||
Transcription regulators | [+] 1 Transcription regulators | + | |||
Interacting Protein Name | Tumor protein p73 (TP73) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P73 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [35] | |||
2 | Reconstituted Complex | [35] | |||
Ubiquitin related proteins | [+] 1 Ubiquitin related proteins | + | |||
Interacting Target Name | Ubiquitin-protein ligase E3 Mdm2 (MDM2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RING-type E3 ubiquitin transferase Mdm2; P53-binding protein Mdm2; Oncoprotein Mdm2; MDM2 protein; Hdm2; E3 ubiquitin-protein ligase Mdm2; Double minute 2 protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [36] | |||
2 | Biochemical Activity | [36] | |||
3 | Protein-peptide | [37] | |||
Other proteins | [+] 7 Other proteins | + | |||
Interacting Target Name | Proto-oncogene c-Crk (c-Crk) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P38; Adapter molecule crk | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [38] | |||
3 | Biochemical Activity | [12] | |||
4 | Reconstituted Complex | [39] | |||
5 | Yeast two hybrid | [40] | |||
Interacting Protein Name | Crk-like protein (CRKL) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Reconstituted Complex | [41] | |||
3 | Yeast two hybrid | [41] | |||
Interacting Protein Name | Docking protein 1 (DOK1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P62DOK | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [42] | |||
2 | Biochemical Activity | [43] | |||
3 | Reconstituted Complex | [44] | |||
Interacting Target Name | DNA repair protein RAD51 homolog 1 (RAD51) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RECA; RAD51A; RAD51 homolog A; HsRAD51; HRAD51 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [20] | |||
2 | Reconstituted Complex | [20] | |||
Interacting Protein Name | Abl interactor 1 (ABI1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ABI.1; ABLBP4; E3B1; NAP1BP; SSH3BP; SSH3BP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [45] | |||
2 | Biochemical Activity | [46] | |||
Interacting Protein Name | Abl interactor 2 (ABI2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ABI.2; ABI2B; AIP.1; AblBP3; SSH3BP2; argBP1; argBPIA; argBPIB | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Yeast two hybrid | [47] | |||
Interacting Protein Name | SHC-transforming protein 1 (SHC1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SHC; SHCA | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [32] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci U S A. 2009 May 5;106(18):7414-9. | ||||
REF 2 | Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2. Genes Chromosomes Cancer. 2006 Dec;45(12):1121-9. | ||||
REF 3 | Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor. Oncogene. 2001 Jul 5;20(30):4058-69. | ||||
REF 4 | Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J Biol Chem. 1996 Apr 5;271(14):8435-42. | ||||
REF 5 | Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation. Mol Cell Biol. 2002 Jun;22(12):4020-32. | ||||
REF 6 | Detection of transient protein-protein interactions by bimolecular fluorescence complementation: the Abl-SH3 case. Proteomics. 2007 Apr;7(7):1023-36. | ||||
REF 7 | Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16691-6. | ||||
REF 8 | Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease. J Neurosci. 2011 Jan 5;31(1):157-63. | ||||
REF 9 | The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr. J Biol Chem. 1997 Dec 26;272(52):33260-70. | ||||
REF 10 | Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 1994 Apr 1;8(7):783-95. | ||||
REF 11 | Requirement of multiple SH3 domains of Nck for ligand binding. Cell Signal. 1999 Apr;11(4):253-62. | ||||
REF 12 | JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat Cell Biol. 2005 Mar;7(3):278-85. | ||||
REF 13 | Interaction of BCR-ABL with the retinoblastoma protein in Philadelphia chromosome-positive cell lines. Int J Hematol. 1997 Feb;65(2):115-21. | ||||
REF 14 | Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev. 1995 Jan 1;9(1):31-46. | ||||
REF 15 | Physical and functional interaction between hMSH5 and c-Abl. Cancer Res. 2006 Jan 1;66(1):151-8. | ||||
REF 16 | Evidence for a direct involvement of hMSH5 in promoting ionizing radiation induced apoptosis. Exp Cell Res. 2009 Aug 15;315(14):2420-32. | ||||
REF 17 | A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood. 1999 Apr 15;93(8):2707-20. | ||||
REF 18 | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell. 2012 Aug 31;150(5):987-1001. | ||||
REF 19 | Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis. Blood. 2011 Mar 17;117(11):3151-62. | ||||
REF 20 | Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem. 1999 Apr 30;274(18):12748-52. | ||||
REF 21 | Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status. Cancer Res. 2007 Apr 1;67(7):3010-7. | ||||
REF 22 | Interaction between ATM protein and c-Abl in response to DNA damage. Nature. 1997 May 29;387(6632):520-3. | ||||
REF 23 | The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92. | ||||
REF 24 | In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84. | ||||
REF 25 | A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006 Jan 12;439(7073):168-74. | ||||
REF 26 | Reciprocal regulation of Abl and receptor tyrosine kinases. Cell Signal. 2009 Jul;21(7):1143-50. | ||||
REF 27 | Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. J Neurosci Res. 2000 Feb 1;59(3):356-64. | ||||
REF 28 | Direct interaction of nerve growth factor receptor, TrkA, with non-receptor tyrosine kinase, c-Abl, through the activation loop. FEBS Lett. 2000 Mar 3;469(1):72-6. | ||||
REF 29 | A positive role for c-Abl in Atm and Atr activation in DNA damage response. Cell Death Differ. 2011 Jan;18(1):5-15. | ||||
REF 30 | Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem. 1999 Dec 31;274(53):37538-43. | ||||
REF 31 | Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response. J Biol Chem. 2003 Apr 11;278(15):12961-7. | ||||
REF 32 | Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 1994 Feb 15;13(4):764-73. | ||||
REF 33 | BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell. 1991 Jul 12;66(1):161-71. | ||||
REF 34 | Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase. J Biol Chem. 1994 Jan 21;269(3):1927-33. | ||||
REF 35 | p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature. 1999 Jun 24;399(6738):814-7. | ||||
REF 36 | Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J. 2002 Jul 15;21(14):3715-27. | ||||
REF 37 | Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase. Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1749-54. | ||||
REF 38 | Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity. 2008 Oct 17;29(4):578-88. | ||||
REF 39 | c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 1994 May 15;13(10):2341-51. | ||||
REF 40 | The SH2-containing adapter protein GRB10 interacts with BCR-ABL. Oncogene. 1998 Aug 27;17(8):941-8. | ||||
REF 41 | Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation. Blood. 1997 Jan 1;89(1):297-306. | ||||
REF 42 | A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice. PLoS One. 2009 Oct 13;4(10):e7439. | ||||
REF 43 | Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell. 1997 Jan 24;88(2):205-11. | ||||
REF 44 | Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins. J Biol Chem. 1998 Nov 27;273(48):32360-8. | ||||
REF 45 | Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth. Oncogene. 1997 Jan 16;14(2):233-41. | ||||
REF 46 | Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1. Biochim Biophys Acta. 2008 May;1783(5):737-47. | ||||
REF 47 | Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor. BMC Cancer. 2016 May 26;16:335. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.